Total Payments
$13,938
2024 Payments
$2,471
Companies
41
Transactions
701
Medicare Patients
4,779
Medicare Billing
$473,704
Payment Breakdown by Category
Food & Beverage$13,701 (98.3%)
Education$236.94 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,701 | 698 | 98.3% |
| Education | $236.94 | 3 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,969 | 98 | $0 (2024) |
| Janssen Biotech, Inc. | $1,332 | 53 | $0 (2024) |
| LEO Pharma Inc. | $910.25 | 50 | $0 (2024) |
| ABBVIE INC. | $814.76 | 40 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $785.97 | 41 | $0 (2024) |
| Amgen Inc. | $745.52 | 35 | $0 (2024) |
| Almirall LLC | $673.05 | 30 | $0 (2024) |
| Galderma Laboratories, L.P. | $631.78 | 40 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $476.50 | 14 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $470.37 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,471 | 102 | Arcutis Biotherapeutics, Inc. ($331.79) |
| 2023 | $2,273 | 110 | Novartis Pharmaceuticals Corporation ($325.98) |
| 2022 | $1,935 | 106 | Novartis Pharmaceuticals Corporation ($304.93) |
| 2021 | $1,629 | 79 | Novartis Pharmaceuticals Corporation ($269.19) |
| 2020 | $932.99 | 44 | Novartis Pharmaceuticals Corporation ($171.76) |
| 2019 | $1,780 | 89 | Novartis Pharmaceuticals Corporation ($197.56) |
| 2018 | $1,523 | 85 | Novartis Pharmaceuticals Corporation ($256.55) |
| 2017 | $1,394 | 86 | Janssen Biotech, Inc. ($161.94) |
All Payment Transactions
701 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/18/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Dermatology | ||||||
| 11/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Immunology | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.58 | General |
| 10/30/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $33.83 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.99 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.87 | General |
| Category: Dermatology | ||||||
| 09/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Dermatology | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,396 | 2,573 | $322,949 | $136,459 |
| 2022 | 14 | 1,514 | 3,043 | $351,951 | $157,565 |
| 2021 | 13 | 1,121 | 1,996 | $254,617 | $118,008 |
| 2020 | 10 | 748 | 1,154 | $151,746 | $61,672 |
Total Patients
4,779
Total Services
8,766
Medicare Billing
$473,704
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 595 | 988 | $160,056 | $73,311 | 45.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 181 | 200 | $44,600 | $17,479 | 39.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 188 | 253 | $36,432 | $13,306 | 36.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 120 | 120 | $28,080 | $10,163 | 36.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 60 | 81 | $20,169 | $8,261 | 41.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 20 | 25 | $8,700 | $3,832 | 44.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 118 | 509 | $6,526 | $3,133 | 48.0% |
| 10040 | Acne surgery | Office | 2023 | 19 | 20 | $4,840 | $1,929 | 39.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 29 | 40 | $4,840 | $1,762 | 36.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 14 | $3,906 | $1,651 | 42.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 26 | 30 | $3,570 | $1,431 | 40.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 29 | 293 | $1,230 | $201.42 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 564 | 942 | $153,036 | $75,193 | 49.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 203 | 223 | $49,729 | $20,986 | 42.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 157 | 157 | $36,666 | $14,859 | 40.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 171 | 226 | $32,544 | $12,268 | 37.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 92 | 119 | $29,631 | $12,216 | 41.2% |
| 10040 | Acne surgery | Office | 2022 | 30 | 36 | $8,712 | $4,022 | 46.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 16 | 19 | $6,612 | $3,180 | 48.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 28 | $6,524 | $2,871 | 44.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 105 | 449 | $5,811 | $2,856 | 49.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 43 | 53 | $6,188 | $2,512 | 40.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 39 | 53 | $6,413 | $2,401 | 37.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 15 | 15 | $4,185 | $1,921 | 45.9% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 12 | 13 | $3,770 | $1,630 | 43.2% |
About Dr. Amy Slear, MD
Dr. Amy Slear, MD is a Dermatology healthcare provider based in Hicksville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356354203.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Slear, MD has received a total of $13,938 in payments from pharmaceutical and medical device companies, with $2,471 received in 2024. These payments were reported across 701 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($13,701).
As a Medicare-enrolled provider, Slear has provided services to 4,779 Medicare beneficiaries, totaling 8,766 services with total Medicare billing of $473,704. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Hicksville, NY
- Active Since 08/14/2006
- Last Updated 09/29/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1356354203
Products in Payments
- COSENTYX (Biological) $1,279
- TREMFYA (Drug) $749.57
- COSENTYX (Drug) $598.11
- Otezla (Drug) $547.54
- DUPIXENT (Biological) $529.13
- ENSTILAR (Drug) $434.56
- OPZELURA (Drug) $375.46
- KERYDIN (Drug) $372.53
- Zoryve (Drug) $331.79
- SKYRIZI (Biological) $330.19
- ADBRY (Biological) $297.45
- Klisyri (Drug) $295.28
- Tremfya (Drug) $292.29
- EUCRISA (Drug) $271.54
- Humira (Biological) $252.45
- Seysara (Drug) $241.31
- Sotyktu (Drug) $215.74
- Finacea (Drug) $203.39
- Absorica LD (Drug) $192.79
- Winlevi (Drug) $185.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.